Earth Science Tech, Inc.

ETST

US2703111037

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 18:25:39 08/05/2024 BST			5-day change	1st Jan Change
0.11 ^USD	+22.22%		+15.79%	+57.82%

04-29	Tranche Update on Earth Science Tech, Inc.'s Equity Buyback Plan announced on January 29, 2024.	CI
04-19	Earth Science Tech, Inc. Appoints Christopher Rose as Chief Technology Officer	CI

Earth Science Tech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023

July 27, 2023 at 09:54 pm

Earth Science Tech, Inc. reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was USD 0.219934 million. Net loss was USD 0.089708 million compared to USD 0.154682 million a year ago.

Latest news about Earth Science Tech, Inc.

Tranche Update on Earth Science Tech, Inc.'s Equity Buyback Plan announced on January 29, 2024.	04-29	CI
Earth Science Tech, Inc. Appoints Christopher Rose as Chief Technology Officer	04-19	CI
Mario G. Tabraue Relinquish His Role as President of Earth Science Tech, Inc	04-15	CI
Earth Science Tech, Inc. Announces CFO Changes	03-05	CI
Earth Science Tech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-20	CI
Earth Science Tech, Inc. announces an Equity Buyback for $5 million worth of its shares.	01-29	CI
Earth Science Tech, Inc. authorizes a Buyback Plan.	01-28	CI
Earth Science Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-13	CI
Earth Science Tech, Inc. Announces Board Appointments	11-08	CI
Earth Science Tech, Inc. Announces the Resignation Nickolas S. Tabraue as Chief Compliance Officer	16/08/23	CI
Earth Science Tech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	27/07/23	CI
Earth Science Tech, Inc. Announces CFO Changes	17/07/23	CI
Earth Science Tech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	20/06/23	CI
Earth Science Tech, Inc. Auditor Raises 'Going Concern' Doubt	19/06/23	CI
Insider Buy: Earth Science Tech	16/06/23	MT
Insider Buy: Earth Science Tech	07/06/23	MT
Earth Science Tech, Inc. Announces Executive Changes	14/02/23	CI
Earth Science Tech, Inc. Announces Board Changes	14/02/23	CI
Earth Science Tech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/02/23	CI
Earth Science Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22	CI
Earth Science Tech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	15/08/22	CI
Earth Science Tech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	15/07/22	CI
Earth Science Tech, Inc. Auditor Raises 'Going Concern' Doubt	14/07/22	CI
Earth Science Tech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	28/04/22	CI
Earth Science Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	22/11/21	CI

Chart Earth Science Tech, Inc.

Duration

Period

More charts

Company Profile

Earth Science Tech, Inc. is a holding company in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is a complete compounding pharmacy. RxCompound is licensed to fulfill prescriptions in the states of Florida, New York, New Jersey, Delaware, Pennsylvania, Rhode Island, Nevada, Colorado, and Arizona. Peaks is a telemedicine referral site focused on menâs health. Peaks orders are fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. Peaks is focused on menâs health, and, more specifically, ED. ESF accepts grants and donations to help those in need of assistance in paying for prescriptions.

Sector

Pharmaceuticals

Calendar

25/07/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EARTH SCIENCE TECH, INC.	+57.82%	34.1M
ELI LILLY AND COMPANY	+32.95%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.97%	358B
MERCK & CO., INC.	+18.83%	328B
ABBVIE INC.	+3.54%	283B
ASTRAZENECA PLC	+16.11%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+6.70%	165B